CytomX Therapeutics (CTMX) Non-Current Assets (2014 - 2026)
CytomX Therapeutics (CTMX) posted Non-Current Assets of $8.07 million for Q2 2026, down 22.7% from $10.44 million a year earlier but up 28.9% from the prior quarter.
Powered by 
Analysis
CytomX Therapeutics (CTMX) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, CytomX Therapeutics' Non-Current Assets came in at $7.65 million, down 42.2% from FY2024.
- Annual Non-Current Assets has declined for six consecutive years, with a five-year compound annual growth rate of -26.1% (FY2020 to FY2025).
- In prior years, CytomX Therapeutics' Non-Current Assets was $13.23 million in FY2024 (-29.8%), $18.86 million in FY2023 (-20.7%), $23.79 million in FY2022 (-18.3%) and $29.11 million in FY2021 (-16.0%).
- Quarterly Non-Current Assets has run from a low of $6.26 million in Q1 2026 to a high of $130.24 million in Q3 2021 over five years.
- On a year-over-year basis, Non-Current Assets has declined in each of the last 19 quarters, with an average decline of 34.3% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2021, with growth of 273.4%; the weakest was Q3 2022, with a decline of 79.9%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $6.26 million (Q1 2026), $7.65 million (Q4 2025) and $9.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | CytomX Therapeutics | 586.15 Mn | -371.52 Mn | - | 8.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.07 Mn |
| Mar 31, 2026 | 6.26 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Sep 30, 2025 | 9.04 Mn |
| Jun 30, 2025 | 10.44 Mn |
| Mar 31, 2025 | 11.87 Mn |
| Dec 31, 2024 | 13.23 Mn |
| Sep 30, 2024 | 14.80 Mn |
| Jun 30, 2024 | 16.14 Mn |
| Mar 31, 2024 | 17.44 Mn |
| Dec 31, 2023 | 18.86 Mn |
| Sep 30, 2023 | 19.96 Mn |
| Jun 30, 2023 | 21.38 Mn |
| Mar 31, 2023 | 22.35 Mn |
| Dec 31, 2022 | 23.79 Mn |
| Sep 30, 2022 | 26.21 Mn |
| Jun 30, 2022 | 27.32 Mn |
| Mar 31, 2022 | 28.38 Mn |
| Dec 31, 2021 | 29.11 Mn |
| Sep 30, 2021 | 130.24 Mn |
API Access
CytomX Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=CTMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "CTMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=CTMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();